Flerie AB (publ) (STO:FLERIE)

Sweden flag Sweden · Delayed Price · Currency is SEK
44.53
+0.53 (1.20%)
Mar 25, 2025, 1:56 PM CET
-18.74%
Market Cap 3.48B
Revenue (ttm) 2.70M
Net Income (ttm) -228.00M
Shares Out 78.07M
EPS (ttm) -3.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,034
Average Volume 22,328
Open 44.01
Previous Close 44.00
Day's Range 44.01 - 45.20
52-Week Range 41.03 - 57.00
Beta n/a
RSI 47.22
Earnings Date Apr 23, 2025

About Flerie AB

Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 7
Stock Exchange Nasdaq Stockholm
Ticker Symbol FLERIE
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.